Nephrology Medical News about polycystic kidney disease

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Journal of the American Society of Nephrology, 11/04/09

Lieberthal W et al. – Inhibition of mTOR by rapamycin or one of its analogues represents a potentially novel treatment for autosomal dominant polycystic kidney disease. Finally, inhibitors of mTOR improve survival in patients with metastatic renal cell carcinoma.

<< Previous
A case of minimal change disease in a Fabry patient

Next >>
Severe atypical HUS caused by CFH S1191L--case presentation and...

Cystic Changes of Breast in a Family With Autosomal Dominant Polycystic Kidney Disease
Iranian Journal of Kidney Diseases, 10/13/09 Relevance Score: 82%

Autosomal Dominant Polycystic Kidney Disease: Current and Emerging Treatments
Kidney, 10/30/09 Relevance Score: 81%

Autosomal Dominant Polycystic Kidney Disease: New Treatment Options and How to Test Their Efficacy
Kidney and Blood Pressure Research, 11/06/09 Relevance Score: 80%

Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1
Human Molecular Genetics, 11/03/09 Relevance Score: 80%

Psoas abscess in hemodialysis patients
International Urology and Nephrology, 10/06/09 Relevance Score: 80%